AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma
Antibodies that bind to two targets are an established way of treating the blood cancer multiple myeloma. Aiming to top ...
Antibodies that bind to two targets are an established way of treating the blood cancer multiple myeloma. Aiming to top ...
One of the more competitive targets in lung cancer is a certain mutation that has eluded many available targeted therapies. ...
Regeneron Pharmaceuticals is expanding its cancer drug lineup with FDA approval of a bispecific antibody it developed for multiple myeloma, ...
Health Secretary Robert F. Kennedy Jr. is facing renewed scrutiny after declaring the public should "stop trusting experts" while unveiling ...
In a setback to Johnson & Johnson, a federal judge ruled that a U.S. government agency did not violate the ...
A Nektar Therapeutics drug has met the skin clearance goals of a closely watched mid-stage clinical trial in atopic dermatitis. ...
CHICAGO — Late-stage results of Novo Nordisk’s obesity candidate CagriSema suggest the drug is comparable to Eli Lilly’s Zepbound on ...
CHICAGO — Novo Nordisk’s next-generation obesity injection targeting the amylin hormone showed substantial weight loss in an early study, but ...
A Merck drug developed to prevent disease from respiratory syncytial virus (RSV) in infants has won FDA approval, introducing competition ...
Yearly change (95% CI) on the HDDMS, cUHDRS, and cUHDRS components by CAG category. Credit: Brain (2025). DOI: 10.1093/brain/awaf127 A ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.